Literature DB >> 22426394

The role of mitochondrial OXPHOS dysfunction in the development of neurologic diseases.

M E Breuer1, W J Koopman, S Koene, M Nooteboom, R J Rodenburg, P H Willems, J A M Smeitink.   

Abstract

The development of neurologic disease is a complex and multi-faceted process. Several factors, such as physiology, environment and genetics may play key roles in the manifestation of the associated illnesses. During the past decades, it has become clear that, at the cellular level, mitochondria function as more than "just" an energy source for our cells and plays a significant role in such aspects as neuronal development, maintenance and degeneration. Malfunctions in mitochondrial respiration and ATP production may prove disastrous for our cells and neurons, ultimately resulting in apoptosis, neurodegeneration and consequently, neurodegenerative diseases.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22426394     DOI: 10.1016/j.nbd.2012.03.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  27 in total

1.  Evidence of hormesis on human neuronal SK-N-BE cells treated with sodium arsenate: impact at the mitochondrial level.

Authors:  Wafa Kharroubi; Samia Haj Ahmed; Thomas Nury; Pierre Andreoletti; Zohra Haouas; Amira Zarrouk; Rachid Sakly; Mohamed Hammami; Gérard Lizard
Journal:  Environ Sci Pollut Res Int       Date:  2016-01-19       Impact factor: 4.223

2.  Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function.

Authors:  Austin Ferro; Emily Carbone; Evan Marzouk; Asher Siegel; Donna Nguyen; Kailen Polley; Jessilyn Hartman; Kimberley Frederick; Stephen Ives; Sarita Lagalwar
Journal:  J Vis Exp       Date:  2017-01-22       Impact factor: 1.355

3.  Assessment of in vivo skeletal muscle mitochondrial respiratory capacity in humans by near-infrared spectroscopy: a comparison with in situ measurements.

Authors:  Terence E Ryan; Patricia Brophy; Chien-Te Lin; Robert C Hickner; P Darrell Neufer
Journal:  J Physiol       Date:  2014-06-20       Impact factor: 5.182

4.  A mitochondrial RNAi screen defines cellular bioenergetic determinants and identifies an adenylate kinase as a key regulator of ATP levels.

Authors:  Nathan J Lanning; Brendan D Looyenga; Audra L Kauffman; Natalie M Niemi; Jessica Sudderth; Ralph J DeBerardinis; Jeffrey P MacKeigan
Journal:  Cell Rep       Date:  2014-04-24       Impact factor: 9.423

Review 5.  Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.

Authors:  Oded Bergman; Dorit Ben-Shachar
Journal:  Can J Psychiatry       Date:  2016-08       Impact factor: 4.356

6.  Mitochondrial Dysfunction in Psychiatric Illness.

Authors:  Rebecca Anglin
Journal:  Can J Psychiatry       Date:  2016-08       Impact factor: 4.356

Review 7.  How to deal with oxygen radicals stemming from mitochondrial fatty acid oxidation.

Authors:  D Speijer; G R Manjeri; R Szklarczyk
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-07-05       Impact factor: 6.237

8.  Efficient 31 P band inversion transfer approach for measuring creatine kinase activity, ATP synthesis, and molecular dynamics in the human brain at 7 T.

Authors:  Jimin Ren; A Dean Sherry; Craig R Malloy
Journal:  Magn Reson Med       Date:  2016-11-20       Impact factor: 4.668

Review 9.  An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer's Disease.

Authors:  Blaise W Menta; Russell H Swerdlow
Journal:  Neurochem Res       Date:  2018-08-06       Impact factor: 3.996

10.  Identification of 4-N-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine as a novel, highly potent and specific inhibitor of mitochondrial complex I.

Authors:  Robin Krishnathas; Erik Bonke; Stefan Dröse; Volker Zickermann; Hamid R Nasiri
Journal:  Medchemcomm       Date:  2017-02-20       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.